|
2010 Conference Publication Ebv-Positive Dlbcl of the Elderly Is a Distinct Clinico-Biological Entity with Poor Outcome in Chop-R Treated PatientsGandhi, M., Keane, C., Nourse, J., Jones, K., Ross, N., Han, E. and Nguyen-Van, D. (2010). Ebv-Positive Dlbcl of the Elderly Is a Distinct Clinico-Biological Entity with Poor Outcome in Chop-R Treated Patients. 15th Annual Meeting of the European-Hematology-Association, Barcelona Spain, June 10-13, 2010. Pavia, Italy: Fondazione Ferrata Storti. |
|
2009 Conference Publication EBV MicroRNA Expression in Virus Driven B-Cell Differentiation and LymphomagenesisNourse, Jamie P., Crooks, Pauline, Van, Do Nguyen, Jones, Kimberley, Ross, Nathan and Gandhi, Maher K. (2009). EBV MicroRNA Expression in Virus Driven B-Cell Differentiation and Lymphomagenesis. 51st Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 05-08, 2009. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2009 Conference Publication Cell-free Epstein-Barr Virus DNA is a Specific Biomarker for Tumor Burden in EBV-associated LymphomasJones, Kimberley, Nourse, J., Crooks, P., Gottlieb, D. and Gandhi, Mahei (2009). Cell-free Epstein-Barr Virus DNA is a Specific Biomarker for Tumor Burden in EBV-associated Lymphomas. 24th Annual Meeting of the International-Society-for-Biology-Therapy-of-Cancer, Washington Dc, Oct 29-31, 2009. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2009 Conference Publication Epstein-Barr Virus-specific T Cells as Therapy for Relapsed/Refractory EBV-positive LymphomasJones, Kimberley, Vari, Frank, Khanna, Rajiv, Han, Erica, Singh, Sanjleena, Ritchie, David and Gandhi, Maher K. (2009). Epstein-Barr Virus-specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas. 24th Annual Meeting of the International-Society-for-Biology-Therapy-of-Cancer, Washington Dc, Oct 29-31, 2009. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2009 Conference Publication Mechanisms Underlying the Selective Impairment of Epstein Barr Virus-Nuclear Antigen I-specific Effector T Cells Observed in PTLDJones, Kimberley, Nouise, J., Morrison, L., Vari, Frank, Moss, D. and Gandhi, Mahei K. (2009). Mechanisms Underlying the Selective Impairment of Epstein Barr Virus-Nuclear Antigen I-specific Effector T Cells Observed in PTLD. 24th Annual Meeting of the International-Society-for-Biology-Therapy-of-Cancer, Washington Dc, Oct 29-31, 2009. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2009 Journal Article Selective accumulation of virus-specific CD8(+) T cells within the peripheral blood stem cell compartmentSingh, Sanjleena, van Hauten, Paulien, Jones, Kimberley, Grimmett, Karen, Mills, Anthony K. and Gandhi, Maher K. (2009). Selective accumulation of virus-specific CD8(+) T cells within the peripheral blood stem cell compartment. Blood, 114 (9), 2001-2003. doi: 10.1182/blood-2009-05-221267 |
|
2009 Conference Publication Ebv Microrna Expression in An In-Vitro Model of B-Cell Differentiation and LymphomagenesisNourse, P., Jones, K., Crooks, P. and Gandhi, M. K. (2009). Ebv Microrna Expression in An In-Vitro Model of B-Cell Differentiation and Lymphomagenesis. 14th Annual Meeting of the European-Hematology-Association, Berlin Germany, Jun 04-07, 2009. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2009 Journal Article High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphomaGreen, Michael, Gandhi, Maher K, Camilleri, Emily, Marlton, Paula, Lea, Rod and Griffiths, Lyn (2009). High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma. Leukemia Research, 33 (5), 731-734. doi: 10.1016/j.leukres.2008.09.007 |
|
2009 Journal Article Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: Are we there yet?Jones, Kimberley and Gandhi, Maher K. (2009). Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: Are we there yet?. Leukemia and Lymphoma, 50 (5), 684-686. doi: 10.1080/10428190902847716 |
|
2009 Journal Article What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?Gandhi, Maher K. (2009). What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?. Medical Journal of Australia, 190 (8), 461-461. |
|
2009 Journal Article The role of Epstein-Barr virus in Richter syndromeNourse, Jamie, Jones, Kimberley and Gandhi, Maher K. (2009). The role of Epstein-Barr virus in Richter syndrome. British Journal of Haematology, 144 (4), 613-613. doi: 10.1111/j.1365-2141.2008.07471.x |
|
2009 Journal Article Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NF kappa B activity in Follicular LymphomaGreen, Michael R., Gandhi, Maher K., Courtney, Mark J., Marlton, Paula and Griffiths, Lyn (2009). Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NF kappa B activity in Follicular Lymphoma. Leukemia Research, 33 (12), 1699-1702. doi: 10.1016/j.leukres.2009.05.004 |
|
2009 Book Chapter Genetic susceptibility to complex traits: moving towards informed analysis of whole-genome screensGreen, Michael R., Camilleri, Emily, Gandhi, Maher K. and Griffiths, Lyn R. (2009). Genetic susceptibility to complex traits: moving towards informed analysis of whole-genome screens. Human genome: features, variations and genetic disorders. (pp. 167-180) edited by Akio Matsumoto and Mai Nakano. New York, NY, United States: Nova Science. |
|
2008 Journal Article Immunodeficiency-associated lymphomasTran, Huy, Nourse, Jamie, Hall, Sara, Green, Michael, Griffiths, Lyn and Gandhi, Maher K. (2008). Immunodeficiency-associated lymphomas. Blood Reviews, 22 (5), 261-281. doi: 10.1016/j.blre.2008.03.009 |
|
2008 Journal Article A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantationHourigan, Matthew J., Doecke, James, Mollee, Peter N., Gill, Devinder S., Norris, Debra, Johnson, David W. and Gandhi, Maher K. (2008). A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation. British Journal of Haematology, 141 (6), 904-907. doi: 10.1111/j.1365-2141.2008.07149.x |
|
2008 Journal Article Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravisTran, Huy, Cheung, Catherine, Gill, Devinder, Dua, Ujjwal, Nourse, Jamie, Boyle, Richard and Gandhi, Maher K. (2008). Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis. Nature Clinical Practice Oncology, 5 (4), 234-238. doi: 10.1038/ncponc1071 |
|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsMollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology. |
|
2007 Journal Article Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disordersGandhi, M., Wilkie, G. M., Dua, U., Mollee, P., Grimmett, K., Williams, T., Whitaker, N., Gill, D. and Crawford, D. (2007). Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders. American Journal of Transplantation, 7 (5), 1293-1299. doi: 10.1111/j.1600-6143.2007.01796.x |
|
2007 Journal Article Epstein-Barr virus T-cell immunity despite rituximabNehring, Angela K., Dua, Ujjwal, Mollee, Peter, Gill, Devinder, Grimmett, Karen, Khanna, Rajiv, Moss, Denis and Gandhi, Maher K. (2007). Epstein-Barr virus T-cell immunity despite rituximab. British Journal of Haematology, 136 (4), 628-632. doi: 10.1111/j.1365-2141.2006.06482.x |
|
2007 Journal Article Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphomaGandhi, Maher K., Moll, Guido, Smith, Corey, Dua, Ujjwal, Lambley, Eleanore, Ramuz, Olivier, Gill, Devinder, Marlton, Paula, Seymour, John F. and Khanna, Rajiv (2007). Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma. Blood, 110 (4), 1326-1329. doi: 10.1182/blood-2007-01-066100 |
